Susan A Wang
Affiliation: Centers for Disease Control and Prevention
- Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001Susan A Wang
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 37:849-52. 2003..This report of the first 3 patients in the United States identified with this multidrug-resistant strain may portend an emerging problem for clinicians and public health officials...
- Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistanceSusan A Wang
National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Emory University School of Medicine, and Emory Center for AIDS Research, Atlanta, Georgia 30333, USA
Ann Intern Med 147:81-8. 2007..Over the past 60 years, Neisseria gonorrhoeae has acquired clinically significant resistance to sulfonamides, tetracyclines, penicillins, and ciprofloxacin...
- The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001Lori M Newman
Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Clin Infect Dis 38:649-54. 2004....
- The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000Catherine A McLean
Division of STD Prevention, Division of AIDS, STD, and TB Laboratory Research Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Sex Transm Dis 31:73-8. 2004..0 microg/mL) in the United States. GOAL The goal of this study was to identify risk factors for AziDS N. gonorrhoeae and to describe isolate microbiology...
- Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeaeKakoli Roy
Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 11:1265-73. 2005..Similarly, culture-based testing and susceptibility surveillance are optimal when the prevalence of gonorrhea is < 13%; nonculture-based testing is optimal (cost-minimizing) when gonorrhea prevalence is > or = 13%...
- Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeaeSteven R Johnson
Gonorrhea Research Branch, Division of AIDS, STD and TB Laboratory Research, NCID, Mailstop C 13, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
Int J Antimicrob Agents 21:414-9. 2003..0 mg/l and inactivation of the mtrD gene reduced azithromycin MICs 270-fold. These results demonstrated that the mtr mutations were responsible for the increased MICs in these isolates...
- Recommendations for identification and public health management of persons with chronic hepatitis B virus infectionCindy M Weinbaum
Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road, MS G 37, Atlanta GA 30333, USA
MMWR Recomm Rep 57:1-20. 2008..This report is intended to serve as a resource for public health officials, organizations, and health-care professionals involved in the development, delivery, and evaluation of prevention and clinical services...
- A pseudo-outbreak of Chlamydia trachomatis in a state residential facility: implications for diagnostic testingDeborah A Gust
Division of STD Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 185:841-4. 2002..For C. trachomatis screening tests, the need for confirmatory testing depends on individual patient considerations (including medical-legal implications) and prevalence of infection in the tested population...
- National survey of sexual behavior and sexual behavior policies in facilities for individuals with mental retardation/developmental disabilitiesDeborah A Gust
National Immunization Program, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, USA
Ment Retard 41:365-73. 2003..Careful monitoring of STDs and the effectiveness of sex education will be instrumental in preventing HIV/STDs and helping prevent sexual abuse in this vulnerable population...
- Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virusBayo C Willis
Immunization Services Division, Centers for Disease Control and Prevention, 1600 Clifton Rd, MS E52, Atlanta, GA 30333, USA
Pediatrics 125:704-11. 2010..The objective of this study was to examine hospital policies and practices to prevent perinatal transmission of hepatitis B virus (HBV) in the United States and to and identify gaps...
- A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescentsEric E Mast
Division of Viral Hepatitis, National Center for Infectious Diseases, USA
MMWR Recomm Rep 54:1-31. 2005..The second part of the ACIP statement, which will include updated recommendations and strategies to increase hepatitis B vaccination of adults, will be published separately...
- Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting reportSusan A Wang
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 191:917-23. 2005..Evaluating C. trachomatis clinical treatment failures, interpreting laboratory findings, and correlating the 2 clearly remain extremely challenging undertakings...
- Human papillomavirus vaccine introduction--the first five yearsLauri E Markowitz
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, Georgia, 30333, US
Vaccine 30:F139-48. 2012..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
- Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003Heidi M Bauer
California Department of Health Services Sexually Transmitted Disease Control Branch, Oakland, CA, USA
Clin Infect Dis 41:795-803. 2005..Rates of fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) are increasing worldwide and in California...
- Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: role of foreign importation and increasing endemic spreadChristopher J Iverson
Epidemic Intelligence Service, Epidemiology Program Office, Hawaii Department of Health, Honolulu, Hawaii
Sex Transm Dis 31:702-8. 2004..In 1999, an increase in ciprofloxacin-resistant Neisseria gonorrhoeae isolates was identified in Hawaii, prompting initiation of investigative studies...
- Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelinesStuart M Berman
Sex Transm Dis 30:528-9; author reply 530. 2003
- How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents?Stanley J Schaffer
Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
Pediatrics 121:S35-45. 2008..Our goal was to evaluate the capacity of various health care settings to supplement the activities of the traditional medical home by delivering vaccines to adolescents...